Efficacy of long-term growth hormone therapy in short non-growth hormone-deficient children

Lucia Schena, Cristina Meazza, Sara Pagani, Valeria Paganelli, Elena Bozzola, Carmine Tinelli, Fabio Buzi, Mauro Bozzola

Research output: Contribution to journalArticlepeer-review


In recent years, several studies have been published showing different responses to growth hormone (GH) treatment in idiopathic short stature children. The aim of the present study was to investigate whether non-growth-hormone-deficient (non-GHD) short children could benefit from long-term GH treatment as GHD patients. We enrolled 22 prepubertal children and 22 age- and sex-matched GHD patients, with comparable height, body mass index (BMI), bone age, and insulin-like growth factor 1 (IGF-I) circulating levels. The patients were treated with recombinant human GH (rhGH) and followed until they reach adult height. During GH treatment, the two groups grew in parallel, reaching the same final height-standard deviation score (SDS) and the same height gain. On the contrary, we found significantly lower IGF-I serum concentrations in non-GHD patients than in GHD ones, at the end of therapy (p=0.0055). In our study, the response to GH treatment in short non-GHD patients proved to be similar to that in GHD ones. However, a careful selection of short non-GHD children to be treated with GH would better justify the cost of long-term GH therapy.
Original languageEnglish
Pages (from-to)197-201
Number of pages5
JournalJournal of Pediatric Endocrinology and Metabolism
Issue number2
Publication statusPublished - Feb 1 2017


  • Adult height, Growth hormone, Growth hormone treatment, Insulin-like growth factor-I, Short stature


Dive into the research topics of 'Efficacy of long-term growth hormone therapy in short non-growth hormone-deficient children'. Together they form a unique fingerprint.

Cite this